Cargando…
Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
Background. Exhaled nitric oxide (eNO) is a potential biomarker to distinguish systemic sclerosis (SSc) associated pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD). We evaluated the discriminative validity, feasibility, methods of eNO measurement, and magnitude of difference...
Autores principales: | Kozij, Natalie K., Granton, John T., Silkoff, Philip E., Thenganatt, John, Chakravorty, Shobha, Johnson, Sindhu R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331166/ https://www.ncbi.nlm.nih.gov/pubmed/28293128 http://dx.doi.org/10.1155/2017/6736239 |
Ejemplares similares
-
Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study
por: Pasarikovski, Christopher R., et al.
Publicado: (2016) -
Inhaled and exhaled nitric oxide
por: Thébaud, B., et al.
Publicado: (1999) -
Clinical application of exhaled nitric oxide measurement in pediatric lung diseases
por: Manna, Angelo, et al.
Publicado: (2012) -
Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease
por: Annangi, Srinadh, et al.
Publicado: (2022) -
Exhaled nitric oxide in diagnosis and management of respiratory diseases
por: Abba, Abdullah A.
Publicado: (2009)